Home > Boards > US Listed > Biotechs > Sage Therapeutics, Inc. (SAGE)

So this Leerink Swann call of 1/7 is

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
cvm101 Member Profile
 
Followed By 0
Posts 267
Boards Moderated 0
Alias Born 04/18/18
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 5:19:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 5:19:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 5:19:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 5:17:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 5:17:08 PM
Sage Therapeutics to Present at BMO Prescriptions for Success Healthcare Conference Business Wire - 6/18/2019 6:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 9:03:44 AM
Sage Therapeutics Announces U.S. Drug Enforcement Administration Scheduling of ZULRESSO™ (brexanolone) Injection Business Wire - 6/14/2019 8:53:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/6/2019 4:37:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 4:04:04 PM
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire - 6/5/2019 6:30:00 AM
Sage Therapeutics to Present at Goldman Sachs 40th Annual Global Healthcare Conference Business Wire - 6/4/2019 6:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2019 4:04:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/24/2019 6:26:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/24/2019 4:02:12 PM
Wedbush Securities Senior Vice President of Equity Research Laura Chico, Ph.D. Initiates Coverage on Six Stocks in the Health... PR Newswire (US) - 5/23/2019 9:06:00 AM
Sage Therapeutics to Present at 2019 RBC Capital Markets Global Healthcare Conference Business Wire - 5/14/2019 6:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/10/2019 4:36:46 PM
cvm101   Friday, 02/01/19 11:49:24 AM
Re: None
Post # of 81 
So this Leerink Swann call of 1/7 is looking pretty idiotic now as stock crosses $144.00
Earlier they had downgraded and lowered target price to $80.00

Sage Therapeutics stock price target raised to $90 from $80 at Leerink

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist